Disclosures for "INSIGHT-MP: Interpretable Natural Language Processing System for Identification of Transthyretin Amyloidosis with Mixed Phenotype Using Machine Learning"
-
Mr. Arora has nothing to disclose.
-
Ms. Sunderman has nothing to disclose.
-
Ms. da Graca has nothing to disclose.
-
The institution of Dr. Priest has received research support from AstraZeneca. The institution of Dr. Priest has received research support from Boehringer Ingelheim. The institution of Dr. Priest has received research support from CSL Vifor. The institution of Dr. Priest has received research support from Owkin. The institution of Dr. Priest has received research support from Lyda Hill Foundation.
-
Dr. Khan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer.
-
Ms. Hammonds has nothing to disclose.
-
Dr. Bennett has nothing to disclose.
-
Mr. ettlinger has nothing to disclose.
-
Dr. Gottlieb has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam Pharmaceuticals. Dr. Gottlieb has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Gottlieb has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals.
-
John Venditto has received personal compensation for serving as an employee of AstraZeneca . John Venditto has stock in AstraZeneca .
-
Dr. Papas has received personal compensation for serving as an employee of AstraZeneca. Dr. Papas has stock in AstraZeneca.